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Constipation and herbal medicine
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1 Department of Kampo Medicine, Yamaguchi University Hospital, Ube, Japan, 2 Department of Computer Science
and Systems Engineering, Faculty of Engineering, Yamaguchi University, Ube, Japan
Constipation is characterized by a variety of bowel symptoms such as difficulty passing
stool, hard stool, and a feeling of incomplete evacuation. The multifactorial causes of
constipation limit the clinical efficacy of current conventional treatments that use a single
drug that acts through only one pathway. To complement the shortcomings of the current
Western medical model and provide a complete holistic approach, herbal medicines
capable of targeting multiple organs and cellular sites may be used. In Japan, many herbs
and herbal combinations have traditionally been used as foods and medicines. Currently,
Japanese physicians use standardized herbal combinations that provide consistent and
essential quality and quantity. This review highlights representative Japanese herbal
medicines (JHMs), Rhei rhizoma-based JHMs including Daiokanzoto and Mashiningan,
and Kenchuto-based JHMs including Keishikashakuyakuto and Daikenchuto, which
coordinate the motility of the alimentary tract. This review provides a framework to better
understand the clinical and pharmacological efficacies of JHMs on constipation according
to the unique theory of Japanese traditional medicine, known as Kampo medicine.
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Introduction
Constipation is characterized by a variety of bowel symptoms such as difficulty passing stool, hard
stool, and feelings of incomplete evacuation. It is reported that 12–19%ofAmericans (Eoff, 2008) and
14% of Asians (Cheng et al., 2003) suffer from constipation, with symptoms varying by geographic
location (Talley et al., 1993).
The multifactorial causes of constipation limit the clinical efficacy of current conventional
Western treatments since these drugs act through a single pathway (Gallagher andO’Mahony, 2009).
To complement these shortcomings and provide a complete holistic approach, herbal medicines
capable of targeting multiple organ sites may be used (Suzuki et al., 2009). In Japan, many traditional
herbs and herbal combinations are used as foods and medicines (Iizuka et al., 2003), and physicians
currently use standardized herbal combinations with consistent quality and quantity of constituents
(Yakubo et al., 2014).
This four-part review provides a framework to better understand the clinical and pharmacological
efficacy of Japanese herbal medicines (JHMs) on constipation by: (1) explaining the unique theory
of Japanese traditional medicine, or Kampo medicine (KM); (2) summarizing JHMs used for con-
stipation; (3) explaining the clinical application and pharmacological action of Rhei Rhizoma-based
JHMs; and (4) explaining the clinical application and pharmacology of Kenchuto-based JHMs.
The Unique Theory of Japanese Traditional Medicine, or Kampo
Medicine
Kampo medicine is another term for traditional Japanese medicine based on traditional Chinese
medicine (TCM; Tang et al., 2008). The history of KM can be traced to about the fifth or sixth
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TABLE 1 | Japanese herbal medicines (JHMs) and Kampo patterns.
Japanese herbal
medicines (JHMs)
Class Kampo patterns Qi deficiency Qi stagnation Qi counterflow Blood
deficiency
Blood stasis Fluid excess
Daiokanzoto 1 Intermediate
Tokakujokito 1 Excess 
Bofutsushosan 1 Excess 
Tsudosan 1 Excess 
Mashiningan 1 Intermediate
Junchoto 1 Intermediate 
Daikenchuto 2 Deficiency 
Keishikasyakuyakuto 2 Deficiency 
Shokenchuto 2 Deficiency 
Keishikasyakuyakudaioto 2 Deficiency 
Class 1: Rhei-Rhizoma-based JHMs; Class 2: Kenchuto-based JHMs.
century, when TCM was likely introduced to Japan via Korea. At
present, 148 government-regulated prescription JHMs are cov-
ered by Japanese national health insurance. These JHMs are high-
quality herbs in combinations and proportions fixed and stan-
dardized according to classical TCM literature (Watanabe et al.,
2011). Concomitant use of JHMs and various Western drugs is
permitted in daily clinical practice under Japanese national health
insurance.
There is a marked difference between Western medicine and
traditional Asian medicines such as TCM, KM, and traditional
Korean medicine. Western medicine specifically and efficiently
attacks abnormal organs or cells by targeting the cause of the dis-
ease.More specifically,Westernmedicine focuses on pathogenesis
rather than host reaction. In contrast, KM is concerned with the
host’s reaction to the pathogen, and thus focuses on the host’s
inherent ability to promote health by targeting multiple organs or
cells concurrently. This is largely due to the fact that JHMs contain
a combination of herbs, and thus a vast array of constituents. An
evidence-based approach fails to assess efficacy when studying
individualized medicines under the KM system because the end-
points are somewhat unclear. This is an issue that requires further
investigation in future studies.
Similar to TCM, KM uses patterns (Sho in Japanese, and Zheng
in Chinese) to determine a suitable herbal combination for each
patient. While TCM is based on the theory of the Ming Dynasty,
KM was separated from this theory and then reestablished based
on a different theory, Shang Han Lun, during the Edo period
(Yakubo et al., 2014). While organ systems are very important for
determining medication patterns in TCM, they are not utilized
in KM because Japanese KM specialists wish to avoid overlap
with terms used in Western medicine. Thus, KM patterns are
quite unique. One possible reason for this may be the fact that
TCM prescriptions are individualized at the herbal level, while
KM prescriptions are individualized at the formula level (Yakubo
et al., 2014).
For diagnosis in KM, several parameters are provided to formu-
late medication patterns, including yin-yang, deficiency-excess,
cold-heat, interior-exterior, six stages of acute febrile diseases and
Qi-blood-fluid (Sato et al., 2005; Yakubo et al., 2014). To assess
and better understand patient status, KM defines chronic health
conditions as, for example, deficiency, intermediate (i.e., between
deficiency and excess), and excess patterns in the whole body and
Qi-blood-fluid. Qi, or life energy, is sourced from food and air.
There are three types of abnormal Qi patterns: Qi deficiency, Qi
stagnation, and Qi counterflow. Blood is a red fluid moved by Qi.
There are two types of abnormal blood patterns: blood deficiency
and blood stasis. Fluid, in contrast to blood, is a colorless and
transparent liquid. In KM, illness is caused by an imbalance of
these three elements. Under KM theory, constipation is thought
to be caused mainly by a deficiency pattern, specifically Qi defi-
ciency, and other patterns (intermediate or excess) caused by Qi
stagnation, blood deficiency, or blood stasis (Table 1). Physicians
specializing in KM can individualize constipation treatments
using the following four traditional examinationmethods: inspec-
tion, listening and smelling, interviewing, and palpation (Sato
et al., 2005).
JHMs Used for Constipation
Japanese herbal medicines are composed of various medicinal
herbs. The pharmacological actions of JHMs in the body are
largely determined by combinations and interactions between the
herbs, which are used to treat KM patterns, including deficiency-
excess and Qi-blood-fluid. Figure 1 shows representative JHMs
and their ingredients (i.e., herbs) used for constipation. There are
two classes of JHMs, Rhei Rhizoma-based JHMs (class 1) and
Kenchuto-based JHMs (class 2), both of which are frequently used
for constipation (Figure 1; Table 1). Figure 2 also depicts the
functional pharmacological relationship between Western drugs
and the primary herbs used in JHMs. Information concerning
herbs in KM were obtained from an online list of package inserts
(http://plaza.umin.ac.jp/kconsort/framepage.html).
Physicians specializing in KM usually use Rhei Rhizoma-based
JHMs (class 1) to treat constipated patients with excess or inter-
mediate patterns, most of whom show atonic constipation (Iizuka,
2011;Table 1;Figure 2). One possible reason for this is that senno-
side A, aloe-emodin, and rhein, which are the main components
of Rhei Rhizoma, have anti-inflammatory activities (He et al.,
2013), and as a result, draw heat from the patient. Therefore, their
pharmacological actions may cause harm in constipated patients
with deficiency and cold patterns.
The word “Kenchuto” means an herbal combination that can
improve the dysfunction of the alimentary tract (Sato et al.,
2005). Kenchuto is classified into two types, Daikenchuto and
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FIGURE 1 | Representative Japanese herbal medicines (JHMs) used for
constipation. Note that there are two representative JHMs,
Rhei-Rhizoma-based JHMs (class 1) and Kenchuto-based JHMs (class 2) that
are classified by combination patterns of herbs that are obtained from the
package insert of Tsumura Kampo Formulation for Prescription
(http://plaza.umin.ac.jp/kconsort/framepage.html).
FIGURE 2 | Functional relation between Western drugs and Japanese herbal medicines (JHMs) used for constipation. JHMs and their main herbs are
listed along with the corresponding Western drugs. Notably, none of laxatives increase bloodstream in the alimentary tract (adapted from Iizuka, 2011).
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Keishikashakuyakuto, based on herb combinations. Interestingly,
although these two types of JHMs have different herb combina-
tions, they have similar functions in terms of promoting bowel
movements (Figure 1). KM physicians typically use Kenchuto-
based JHMs (class 2) to treat constipated patients with defi-
ciency and cold patterns who also report general fatigue due
to Qi deficiency (Table 1). In Japan, Kenchuto-based JHMs are
frequently prescribed when patients with deficiency and cold
patterns develop constipation-predominant irritable bowel syn-
drome (IBS; Sato et al., 2005). In particular, contraction of the
rectus abdominismuscle (Fukuhikokyu in Japanese) is often found
in patients with constipation-predominant IBS. KM physicians
recognize empirically that Paeoniae Radix, a main component of
Kenchuto-based JHMs, promotes relaxation of the rectus abdo-
minis muscle (Sato et al., 2005) as well as smooth muscle of the
intestinal tract. Therefore, for patients with IBS, contractions of
the rectus abdominis muscle can be used as a selection criterion
for Kenchuto-based JHMs.
Clinical Application and Pharmacology
of Rhei-Rhizoma-Based JHMs
Rhei Rhizoma (Rhubarb in English and Daio in Japanese) is one
of the most frequently used herbs for constipation throughout the
world. Rhei Rhizoma contains dianthrone glucosides (sennosides
A to F) and anthraquinones (e.g., rhein, aloe-emodin, emodin,
physcion, chrysophanol; Hardcastle and Wilkins, 1970; Dreessen
et al., 1981; Ngoc et al., 2008). Among these components, sen-
nosides (i.e., stimulative laxatives), have been well documented
for their pharmacological action on constipation (deWitte, 1993).
Sennosides A and B play a central role in the motility of the ali-
mentary tract as prodrugs that are converted to an active principle,
rheinanthrone, by intestinal microbiota (Hardcastle and Wilkins,
1970; Dreessen et al., 1981). A recent study showed that sennoside
A may exert a laxative effect by inhibiting water transfer from
the intestinal tract to the vascular side via decreasing aquaporin-3
expression in the colon (Kon et al., 2014).
Daiokanzoto is a representative Rhei rhizoma-based JHM that
comprises two herbs (Rhei rhizoma and Glycyrrhizae radix). It
is widely used to treat constipated patients with intermediate
patterns (Table 1). The pharmacological action of Daiokanzoto
appears similar to that of sennoside, a main component of Rhei
Rhizoma (Figure 2). Inversely, a patient’s response to sennoside
may predict the clinical efficacy of Rhei Rhizoma-based JHMs.
For example, KM physicians would not empirically prescribe
Daiokanzoto for constipated patients deemed unresponsive to
sennoside in the medical interview (Iizuka, 2011). Alternatively,
Daiokanzoto has beneficial effects on oral mucositis, a disease
that results from increased cell death induced by chemothera-
peutic agent 5-fluorouracil (5-FU; Yoshida et al., 2014). There-
fore, Daiokanzoto may improve both constipation and quality
of life in cancer patients treated with 5-FU-based chemotherapy,
although further studies are required to gain deeper insight into
its pharmacological actions.
Bofutsushosan, Tsudosan, and Tokakujokito are composed of
two main herbs: Rhei Rhizoma and Anhydrous Mirabilitum
(Bosho in Japanese; Figures 1 and 2). Anhydrous Mirabilitum is
a sodium sulfate similar to magnesium sulfate that acts as a salt-
based laxative (Figure 2). Bofutsushosan, Tsudosan, and Tokaku-
jokito are considered strong laxatives due to their stimulative and
salt-based functions (Iizuka, 2011). Among these three JHMs,
Tsudosan and Tokakujokito are used for constipated patients with
blood stasis (Oketsu in Japanese;Table 1). Several herbs (Carthami
Flos, Sappan Lignum, Angelica Radix, and Persicae Semen) used
in Tsudosan and Tokakujokito improve blood stasis by inhibiting
blood coagulation and causing vasodilation. For example, Angel-
ica Radix contains coumarin derivatives, which have inhibitory
effects on platelet aggregation and blood coagulation (Lee et al.,
2003). Bofutsushosan is also used for constipated patients with
Qi stagnation (Kitai in Japanese; Table 1). Daiokanzoto and these
three JHMs are frequently used in patients with atonic constipa-
tion without deficiency and cold patterns.
Junchoto and Mashiningan are unique Rhei Rhizoma-based
JHMs that contain small amounts of Rhei Rhizoma and Cannabis
Fructus (Mashinin in Japanese; Figure 1). In Japan, KM physi-
cians prescribe Junchoto and Mashiningan exclusively for elderly
patients who have spastic constipation (Figure 2). Cannabis
Fructus contains large amounts of fatty oils, including olein,
linolein, and linolenin, with actions similar to the bulk-forming
laxative, polycarbophil calcium (Montserrat-de la Paz et al.,
2014; Figure 2). In most patients with constipation, Junchoto
or Mashiningan soften stool. Generally, constipated stool is dry,
hard, and difficult to pass. Therefore, the combination of Rhei
Rhizoma, which promotes movement of the alimentary tract, and
Cannabis Fructus, which softens stool, may prove effective for
any type of constipation, including atonic and spastic constipa-
tion (Figure 2). Mashiningan has been proven efficacious for
functional constipation in a randomized double-blind, placebo-
controlled study (Cheng et al., 2011). In that study, 120 patients
with functional constipation were randomized into two groups, a
Mashiningan (Hemp Seed Pill) and a placebo group. Responder
rates for the Mashiningan and placebo groups were 43.3 and
8.3% during treatment and 30.0 and 15.0% at 8-week follow-up,
respectively (P < 0.05). This suggests that Mashiningan increases
complete spontaneous bowel movement, relieves the severity of
constipation and straining to evacuate, and effectively reduces the
need for a laxative.
Clinical Application and Pharmacology
of Kenchuto-Based JHMs
Daikenchuto, one member of the Kenchuto-based JHM family,
has a wide range of pharmacological actions and therefore is the
most commonly prescribed JHM. It is composed of the following
four herbs: processed ginger (Kankyo in Japanese), Ginseng Radix
Rubra (Ninjin in Japanese), Zanthoxyli Fructus (Japanese pepper,
Sansho in Japanese), and Saccharum Granorum (maltose powder
derived from rice, Koi in Japanese; Kono et al., 2009; Figure 1).
Due to a lack of relevant studies, the precise pharmacological
action of SaccharumGranorum, a disaccharide with high osmotic
pressure, remains unclear; however, it is not difficult to suspect
that it might affect stool consistency and the motility of the ali-
mentary tract in a manner similar to that of lactulose, an osmotic
laxative (Figure 3).
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FIGURE 3 | Two major mechanisms of action of Daikenchuto.
Daikenchuto ameliorates the motility of the alimentary tract via four
mechanisms (A to D) and increases blood supply to the alimentary tract with
use of adrenomedullin (ADM) and calcitonin gene-related peptide (CGRP)
system (E). Notably, constituents playing an important role in individual
mechanisms and system are identified.
The pharmacological actions of Daikenchuto, which are
divided into two major putative mechanisms (Figure 3), have
been well studied and documented (Shibata et al., 1999; Satoh
et al., 2001a,b; Kono et al., 2008, 2009; Manabe et al., 2010).
Daikenchuto increases blood supply to and improves the motil-
ity of the alimentary tract. The motility of the alimentary tract
has been improved via the cholinergic neuron system (serotonin
and nicotinic acetylcholine receptors), substance P, motilin, and
transient receptor potential cation channel, subfamily V, member
1 (TRPV1) in several rodent and dog models with use of receptor
antagonists or inhibitors (Nagano et al., 1999; Satoh et al., 2001a,b,
2003; Sato et al., 2004; Kikuchi et al., 2013). Several studies
have shown that oral administration of Daikenchuto by healthy
individuals increases plasma levels of substance P and motilin,
which promote, either directly or indirectly, the motility of the
alimentary tract (Nagano et al., 1999; Sato et al., 2004).
Zanthoxyli Fructus contains hydroxy-sanshools (alpha and
beta), which act as a serotonin receptor agonist via the cholinergic
neuron system to enhance intestinal peristalsis (Figure 3). As
shown in Figure 2, its pharmacological action is similar to that of
the serotonin receptor agonist mosapride. Indeed, it was shown
that the increased intestinal motility induced by Daikenchuto was
inhibited by several serotonin receptor antagonists (Shibata et al.,
1999; Satoh et al., 2001a,b). A recent study by Kono et al. (2013)
demonstrated that hydroxy-sanshools activate intestinal epithelial
transient receptor potential cation channel, subfamily A, member
1 (TRPA1), which is highly expressed in enterochromaffin
cells (serotonin-releasing cells), and may prove to be a novel
target for constipation. In addition to the effects of these
individual constituents, a recent study showed that Daikenchuto
activates nicotinic acetylcholine receptors, which accounts for
its effects on motility (Endo et al., 2014). Kikuchi et al. (2013)
reported that pretreatment with atropine, hexamethonium,
ondansetron (5-hydroxytryptamine-3 receptor antagonist), or
capsazepine (TRPV1 antagonist), inhibited Daikenchuto-induced
colonic contractions in a dog model. This suggests that orally
administeredDaikenchuto stimulates colonicmotility via TRPV1,
muscarinic, nicotinic, and 5-hydroxytryptamine-3 receptors.
TRPV1, formerly known as vanilloid receptor 1, is known as the
capsaicin receptor. Interestingly, 6-gingerol and 6-shogaol, which
are extracted from processed ginger, have vanilloid structures,
and possibly act as TRPV1 stimulators (Figure 3). It has been
reported that hydroxy-sanshools extracted from Zanthoxyli
Fructus also bind to TRPV1 (Koo et al., 2007). These constituents
play an important role in promoting the movement of alimentary
tract via sensory nerves.
Unlike other JHMs used for constipation, Daikenchuto also
increases blood circulation (Figure 3). To the best of our knowl-
edge, no other pharmaceutical laxatives produce this effect.
Increased intestinal blood supply is very fascinating from the
standpoint of long-term maintenance of digestive function. As
shown in Figures 2 and 3, both 6-shogaol extracted from
processed ginger and hydroxyl-alpha-sanshool extracted from
Zanthoxyli Fructus, have been shown to increase intestinal
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circulation via calcitonin gene-related peptide (CGRP) and
adrenomedullin (ADM; Kono et al., 2008). Ginseng Radix has
also been shown to increase blood supply to other organs, includ-
ing brain tissues (Kim et al., 2002). These findings help explain
why KM physicians frequently use Daikenchuto to treat consti-
pated patients with deficiency and cold patterns from poor blood
supply.
Both gingerols and shogaols, constituents of processed ginger,
have anti-inflammatory and circulatory effects in the alimen-
tary tract via modulation of mitogen-activated protein kinase
(MAPK), protein kinase B (Akt), and NF-kB activities (Hung
et al., 2009; Wu et al., 2010; Huang et al., 2011; Li et al., 2013).
Daikenchuto has been shown to significantly attenuate mucosal
damage and adhesion in inflamed colon, and to inhibit elevated
levels of proinflammatory cytokines TNFa and IFNg in the colon
in animalmodels of Crohn’s disease (Kono et al., 2010). This phar-
macological action is explained in part by increased levels of ADM
in small and large intestinal epithelial cells after Daikenchuto
administration (Kono et al., 2010). These findings suggest that
Daikenchuto has anti-colitis effects via the orchestration of several
anti-inflammation pathways, which makes it suitable for treating
patients with IBS or other inflammatory bowel diseases. The
clinical application of these findings is currently underway in
many hospitals throughout Japan, and the clinical efficacy of
Daikenchuto will be elucidated in future studies.
Secondary members of the Kenchuto-based JHM family
include Keishikashakuyakuto, Keishikashakuyakudaioto, and
Shokenchuto, which are more frequently used in patients with
constipation-predominant IBS (Sato et al., 2005; Oka et al., 2014).
It is intriguing that Keishikashakuyakuto has shown antidiarrheal
effects via the inhibition of excessively accelerated small intestinal
movement (Saitoh et al., 1999); it has also been effective for
relieving abdominal pain in patients with diarrhea-predominant
IBS (Sasaki et al., 1998). Taken together, these reports suggest
that Keishikashakuyakuto likely normalizes both accelerated
and inhibited intestinal movements. This dual effect illustrates
how certain herbal combinations, such as JHMs with multiple
components, can help maintain host homeostasis.
Keishikashakuyakuto is composed of the following five herbs:
CinnamomiCortex, PaeoniaeRadix, Zingiberis Rhizoma, Zizyphi
Fructus, and Glycyrrhizae Radix (Figure 1). Among these herbs,
Paeoniae Radix and Glycyrrhizae Radix play a central role in
ameliorating bowel dysfunction in patients with IBS. These two
herbs has been shown to suppress the neurogenic contractions
of the ileum induced by electrical stimulation and ganglionic-
stimulating agents in guinea pigs via inhibition of acetylcholine
(Ach) release from cholinergic nerves and inhibition of Ach action
on ileum smoothmuscle (Maeda et al., 1983). Likewise, their anti-
spasmodic effect on the human colon has been confirmed (Ai
et al., 2006).
In addition to its spasmolytic and smooth muscle-relaxing
effects (Takagi andHarada, 1969b; Hayashi et al., 1990; Tsuji et al.,
2012), Paeoniae Radix has been shown to have anti-inflammatory
and analgesic effects, to inhibit gastric acid secretion and stress-
induced ulceration (Takagi and Harada, 1969a), and to have seda-
tive (Takagi and Harada, 1969a,b) and antidepressant-like effects
in rodent models (Mao et al., 2012). Mao et al. (2012) suggested
that Paeoniae Radix has antidepressant-like effects, which could
be mediated in part by inhibiting monoamine oxidase activity,
hypothalamic-pituitary-adrenal axis activation, oxidative stress,
and upregulated brain-derived neurotrophic expression.
Glycyrrhizin, a main component of Glycyrrhizae Radix, and its
metabolite, 18b-glycyrrhetinic acid, have been reported as likely
responsible for ameliorating dysfunctional glutamate transport in
astrocytes via the inhibition of protein kinase activity (Kawakami
et al., 2010). It has also been reported that after administration
of 18b-glycyrrhetinic acid, about 13% passes through the blood-
brain barrier (Mao et al., 2012). These findings suggest that 18b-
glycyrrhetinic acid in the brain can scavenge excess glutamate
via a transporter, which might be related to the pathophysiology
of bipolar disorder, major depressive disorder (Hashimoto et al.,
2007), and schizophrenia (Schobel et al., 2013). Interestingly,
brain-gut interactions have been suggested to play a central role
in the pathogenesis of IBS (Fichna and Storr, 2012). Therefore,
Keishikashakuyakuto orchestrates brain-gut interactions in IBS
patients, Paeoniae Radix, in addition its direct effect on the ali-
mentary tract, has both sedative and antidepressant-like effects,
and Glycyrrhizae Radix induces upregulation of astrocyte gluta-
mate transport. Thus, JHMs prove useful because they are capable
of targeting multiple and/or distant organs such as the brain or
alimentary tract concomitantly.
Shokenchuto is composed of the five herbs used in Keishi-
kashakuyakuto and Saccharum Granorum (Figures 2 and 3).
Keishikashakuyakudaioto is composed of the five herbs used
in Keishikashakuyakuto, plus a small amount of Rhei Rhizoma
(Figures 2 and 3). Considering that Saccharum Granorum and
Rhei Rhizoma both enhance intestinal movement, it seems that
Shokenchuto and Keishikashakuyakudaioto are stronger laxatives
than Keishikashakuyakuto. However, the manner in which these
three JHMs play important roles in controlling intestinal move-
ment remains unclear. Further studies are needed to elucidate
their specific pharmacological action on constipation.
Conclusion
The authors have reviewed classic JHMs used to treat constipation
and compared the pharmacological actions of KM with those
of Western drugs. In a single-center, randomized, and double-
blind study, Daikenchuto was found to have no significant effect
on gastrointestinal and colonic transit, rectal compliance, anal
sphincter pressure or bowel function in female patients with
functional constipation (Iturrino et al., 2013). The effectiveness
of KM allows physicians to provide individualized treatment to
constipated patients and offer holistic JHMs capable of targeting
multiple organ and cellular sites. However, there are limitations
in the evaluation of the clinical efficacy of JHMs in a randomized
clinical study setting because a placebo formulation that matches
the texture, flavor, and other characteristics of the active drug is
not always available. In addition, it is difficult to accurately eval-
uate herbal efficacy on individual patients with the current study
model. A new strategy for evaluating various herbal combinations,
including JHMs, and exploring pharmacological data may be
needed in order to gain deeper insight into current herb-based
therapies.
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